He L et al.Local blockage of self-sustainable erythropoietin signaling suppresses tumor progression in non-small cell lung cancer.Oncotarget 8:82352-82365 (2017).
Guo H et al.Functional defects in CD4(+) CD25(high) FoxP3(+) regulatory cells in ankylosing spondylitis.Sci Rep 6:37559 (2016).
Zhu YP et al.Reactive stroma component COL6A1 is upregulated in castration-resistant prostate cancer and promotes tumor growth.Oncotarget 6:14488-96 (2015).
Cho KI et al.Differential loss of prolyl isomerase or chaperone activity of Ran-binding protein 2 (Ranbp2) unveils distinct physiological roles of its cyclophilin domain in proteostasis.J Biol Chem 289:4600-25 (2014).
Surana R et al.IL4 limits the efficacy of tumor-targeted antibody therapy in a murine model.Cancer Immunol Res 2:1103-12 (2014).
Lin WC et al.Gain-of-function of Stat5 leads to excessive granulopoiesis and lethal extravasation of granulocytes to the lung.PLoS One 8:e60902 (2013).
Momose S et al.Hyperactivated STAT3 in ALK-positive diffuse large B-cell lymphoma with clathrin-ALK fusion.Hum Pathol 40:75-82 (2009).
Ioannidis S et al.Discovery of pyrazol-3-ylamino pyrazines as novel JAK2 inhibitors.Bioorg Med Chem Lett 19:6524-8 (2009).
Kawaguchi R et al.Priming of peripheral monocytes with prolactin (PRL) sensitizes IFN-gamma-mediated indoleamine 2,3-dioxygenase (IDO) expression without affecting IFN-gamma signaling.J Reprod Immunol 77:117-25 (2008).